Engagement with community liver disease management across the UK: a cross-sectional survey
Open Access
- 5 July 2021
- journal article
- research article
- Published by Royal College of General Practitioners in BJGP Open
- Vol. 5 (5)
- https://doi.org/10.3399/bjgpo.2021.0085
Abstract
Background Liver disease is an increasing cause of premature mortality in the UK. Its management in primary care is not well understood. It is unclear what role commissioning bodies are playing in liver disease in the UK. Aim To assess the level of engagement with community chronic liver disease management among clinical commissioning groups (CCGs) and health authorities across the UK. Design & setting A cross-sectional survey to all UK CCGs and health authorities. Method Survey questions were developed by the British Liver Trust, in collaboration with topic experts, and evaluated structures in place relating to liver disease management at commissioning and health board level. Results There were 159 responses representing 99% UK coverage of CCGs and health boards. Twenty per cent reported an individual responsible for liver disease within their organisation, with 40% and 29% reporting having pathways in place to respond to abnormal liver blood tests and liver disease more generally, respectively. All those reporting use of pathways reported using national guidelines to guide content. Twenty-five per cent made use of transient elastography (FibroScan) and 16% of direct serum fibrosis markers (for example, enhanced liver fibrosis [ELF] score), which are both part of current National Institute for Health and Care Excellence (NICE) guidelines. There was marked regional variation in all areas of engagement surveyed, with Wales having exceptionally high levels of engagement in all areas in contrast to the other nations. Conclusion The results of this survey should be used as a catalyst to highlight necessary regional improvements to the primary care management of chronic liver disease across the UK.Keywords
This publication has 10 references indexed in Scilit:
- Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017BMC Public Health, 2021
- Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver DiseaseThe Journal of Applied Laboratory Medicine, 2020
- Development and implementation of a commissioned pathway for the identification and stratification of liver disease in the communityFrontline Gastroenterology, 2019
- GPs’ experiences and perceptions of early detection of liver disease: a qualitative study in primary careBritish Journal of General Practice, 2018
- Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKThe Lancet, 2018
- Guidelines on the management of abnormal liver blood testsGut, 2017
- The feasibility and acceptability of nurse‐led chronic disease management interventions in primary care: An integrative reviewJournal of Advanced Nursing, 2017
- Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional surveyFrontline Gastroenterology, 2017
- Service provision for liver disease in the UK: a national questionnaire-based surveyClinical Medicine, 2012
- Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settingsEmergencias, 2000